• MR System

    Image Guided Thermal Therapy

    The BSD-2000 3D/MR employs the next generation of non-invasive thermometry.
    MR images are translated to map and visualize temperature, allowing
    for precision placement of the hyperthermic heating zone.
    Not for sale in the United States.
  • BSD-200 3D/MR Open Applicator

    Increase Workflow with
    easier patient access

    The Sigma Eye/MR applicator's side opening allows for more natural
    patient access. The unit can be removed and stored, allowing
    the MR system to be used for traditional imaging.
    Not for sale in the United States.
  • BSD-2000 3D/MR Dr with Patient

    Temperature Imaging during treatment

    There is no interruption during the hyperthermia/imaging process. The patient remains in the
    MR system during the full course of treatment. A water bolus is used to make connection
    between the RF signal and the patient. Circulated water can be cooled or heated for patient comfort.
    Not for sale in the United States.
  • BSD-2000 3D/MR Operator

    Realtime Heat Zone Steering

    A great benefit of image-guided thermal therapy
    is the ability to validate and electronically steer the heat zone to
    ensure proper treatment placement and target temperature.
    Not for sale in the United States.

Who is Pyrexar Medical

By leveraging the therapeutic power of focused heat, Pyrexar Medical seeks to revolutionize cancer care. We aim to enhance traditional cancer therapies, with clinically proven and effective options.

We are committed to continuing to advance these pioneering solutions, as we strive to redefine the landscape of cancer care for a brighter and healthier future.

Pyrexar Medical Quality Certifications

Clinical Evidence Matters

Randomized clinical trials (RCT’s) have show significant improvement in clinical outcomes when hyperthermia was added to radiotherapy and/or chemotherapy. Experts in clinical hyperthermia held a consensus meeting (Kadota Fund International Forum 2004) about the evidence of the published clinical results of the RCT’s. Level 1 evidence was found for bladder cancer, breast cancer, cervical cancer, cancer of the esophagus, lymph nodes of head and neck tumors, rectum cancer, soft tissue sarcoma, malignant melanoma, glioblastoma multiform, and various superficial cancers.

Hyperthermia chart demonstrating proven clinical results
Cancer Immune Modulaton

Heat Matters

According to the standards set by the Society of Thermal Medicine (STM), European Society for Hyperthermic Oncology (ESHO) and the Asian Society of Hyperthermic Oncology (ASHO), the benefits of hyperthermia are fully realized when the tumor temperature reaches 39-43 degrees Celsius.

Heat is known to kill cancer cells, shrink tumor size, increase radiosensitivity, inhibit DNA repair, oxygenate hypoxic tumors, produce heat shock proteins, and increase disease-free survival.

Clinical Study Reveals Increased Longevity

An independent study published in the Journal of the American Medical Association (JAMA) reports on a 10 year patient follow-up to a phase III clinical study on a Soft Tissue Sarcoma Study. In addition to higher CR, the addition of hyperthermia increased the median long-term survival rate from 6.2 to 15.4 years

Infographic of Soft Tissue Sarcoma Study

BSD-2000/3D System Description

The BSD-2000/3D consists of four major subsystems:

  • RF power delivery subsystem.
  • Proprietary, thermistor-based, thermometry subsystem.
  • Computerized monitoring and control subsystem.
  • Applicator subsystem that includes an applicator and patient support system.
  • Various accessories, including a tissue equivalent QA lamp phantom that provides verification of the energy focus, pattern steering, and system operations.

Power Delivery Subsystem

  • Solid-state amplifier with 12-channel independent phase and amplitude adjustment capability.
  • Maximum power output of 0 to 500 watts per channel.
  • Phase accuracy within a 10 degree tolerance.
  • Computer automatically monitors and controls forward and reflected power, phase, and power on each channel.
  • Optimized treatment settings are calculated through the use of treatment planning software tools provided with the system.

Thermometry Subsystem

  • Non-perturbing, electromagnetically insensitive, temperature sensors with an accuracy of +0.2°C over a range of 25 to 52°C.
  • Automated positioning system allows the operator to map the sensor along the length of the catheter in order to determine the temperature profile.
  • Precise calibration capabilities - accurate to 0.05°C over a range of 0°C to 60°C.

Applicator and Patient Support System

  • Optimized power coupling.
  • Optimized patient comfort.
  • Water system automatically fills the bolus and controls the bolus water temperature.
  • Fabric sling comfortably supports patient inside the applicator.
  • Easy patient access and handling.
  • Quick drain capability allows fast access to the patient – 15 seconds for patient access and 30 seconds for a complete drain.

Computer Control System

The entire BSD 2000/3D hyperthermia system is controlled by a PC that is interfaced to all system modules. A large, user-friendly LCD color monitor, keyboard and mouse create an ergonomic operating environment. The system includes a high-resolution color inkjet printer for instant hardcopy treatment reports. The system software incorporates a color Graphic User Interface, automatically guiding the operator through the set-up and treatment procedures and featuring menu-driven selection of treatment parameters.

  • User friendly, intuitive, color graphics interface.
  • Step-by-step guide for setup and treatment procedure.
  • Icon selectable adjustments of the treatment parameters.
  • Tabs allow operator to easily switch between screen displays.
  • Closed -loop feedback system provides automatic monitoring and control of treatment parameters, including power output, frequency, amplitude and phase, tissue temperatures, core temperature, and treatment time.
  • System automatically records, displays, and prints patient treatment data.
  • Control of power and tissue temperature to within ±0.1°C.
  • Data regarding temperatures, RF power level, and RF power control updated every 2 seconds.
  • Control algorithms smoothly adjust heating and cooling rates.
  • The system controls the applied power level in accordance with operator inputs and automatically adjusts the level of power to maintain the operator selected temperatures throughout the treatment.
  • The computer automatically performs numerous safety checks to ensure proper operation of the system and ensure safety for the patient and the operator.

Applicator Subsystem

The Sigma Eye is an elliptically shaped annular phased array applicator that is comprised of a clear plastic shell, 24 radiating dipoles, and a bolus membrane. The Sigma Eye provides improved comfort for patients. The twenty-four dipole antennas of the Sigma Eye maximize the 3D energy convergence at the targeted treatment location.

  • Advanced annular phased array principles create a central focusing of energy, which significantly overcomes the penetration losses of the energy radiated into the body.
  • Phased array applicators allow the operator to shape the heating pattern to the targeted treatment area and achieve selective power targeting at depth for treatment of deep tumors.
  • Dipoles are covered by a thin dielectric layer to prevent contact with the bolus water.
  • Water filled bolus dielectrically loads the individual antennas and provides an energy-confining medium that directs the RF energy into the body.
  • Quick and easy patient setup.
  • Plastic shell provides a clear view of the patient’s surface to allow visual verification of the applicator positioning and to facilitate monitoring of any skin color changes, which would be indicative of surface hot spots.

Benefits of Hyperthermia in Cancer Treatment*

Effects Tumor Cell

In the delicate micro-environment of a cancer cell, heat can lead to direct cell death, shrinking tumor size for easier surgical resection.

Low Toxicity

Very low to no toxicity is often reported when administering hyperthermia. There is no known toxicity build-up from multiple treatments.

Increase Blood Flow

Increased blood flow and perfusion at the tumor site promote oxygenation, increasing radiosensitivity.

Survival Benefit

A phase III clinical study shows an increased survival benefit when hyperthermia was added to traditional therapies.

Inhibits DNA Repair

Hyperthermia, in combination with Radiotherapy, will inhibit the DNA repair cycle of radiation-damaged cancer cells.

Heat Shock Proteins

Tumor cells express heat shock proteins when exposed to hyperthermic temperatures allowing tumor-specific antigens to reach the immune system.

Our Products

 

To serve you better, this website has two viewing options.

Please make a selection before entering this site:

I am looking for products
Within the United States or Outside the United States

 
This website has restricted marketing content for visitors within the United States.